AST-120 (Kremezin®)

DRUG2 trials

Sponsors

Astellas Pharma Inc, Chang Gung Memorial Hospital

Conditions

Acute Kidney DiseaseAcute Kidney Injury (AKI)Healthy

Phase 1

Drug-Drug Interaction Study of TRK-100STP

CompletedNCT00719758

Astellas Pharma IncHealthy

Start: 2008-06-30End: 2008-09-30Updated: 2008-10-13

Phase 4

AST-120 (Kremezin®) for the Renal Protection and Attenuation of Decline in Acute Kidney Disease

RecruitingNCT07182422

Chang Gung Memorial HospitalAcute Kidney Disease, Acute Kidney Injury (AKI)

Start: 2025-09-15End: 2027-03-13Target: 100Updated: 2025-09-19